111 INC YI
SPONSORED ADS · ADR · CUSIP 68247Q201
- SectorConsumer staples
- IndustryRetail-Drug Stores and Proprietary Stores
- FilingsSEC EDGAR
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $11.97. Options: 1 managers hold calls ($0 notional), 1 hold puts ($0).
Trends to Q2 2025
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q4 2024 | 2 |
| Q1 2025 | 10 |
| Q2 2025 | 10 |
Buyers vs sellers
Managers adding to or starting a position, vs cutting or selling out
Numbers
| Quarter | Bought or added | Cut or sold out |
|---|---|---|
| Q1 2025 | 8 | 1 |
| Q2 2025 | 3 | 3 |
Biggest buyers
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | New | +14.8k |
| UBS Group AG | Added | +4.7k |
| RENAISSANCE TECHNOLOGIES LLC | Added | +200 |
Biggest sellers
| Deuterium Capital Management, LLC | Sold out | -10.0k |
| JPMORGAN CHASE & CO | Reduced | -62 |
| SBI Securities Co., Ltd. | Reduced | -38 |
Biggest calls
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | Unchanged | $00 shares |
Biggest puts
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | Unchanged | $00 shares |
Options at notional value: the value of the shares the contracts control, as filers report them, not what the options cost. Not included in the holders, shares or buying above.
Major shareholders (over 5%)
Anyone who owns more than 5% of a class of the company's shares has to say so: on Schedule 13D if they may try to influence or control the company, on 13G if they're a passive investor, and update it as the stake changes. Each holder's latest filing, from 19 Dec 2024 on; percentages are of the share class, as the holder worked them out.
| Holder | Stake |
|---|---|
Gang Yu
13D · may seek influence
new · filed 2026-09-17
Stated purposeOn September 16, 2026, Gang Yu, Junling Liu, Sunny Bay Global Limited and Huadeng Tech BioArray Ventures Ltd (collectively, the Consortium) entered into a consortium agreement (the Consortium Agreement), pursuant to which the Consortium will cooperate in good faith in connection with an acquisition transaction (Proposed Transaction) with respect to the Issuer as contemplated by the Proposal (as defined below). The Consortium Agreement provides, among others, for (i) cooperation in negotiation with the Issuer with respect to the Proposed Transaction; (ii) cooperation in engaging advisors; and (iii) cooperation in entry into definitive documentation with respect to the Proposed Transaction. During the period continuing for six months after signing of the Consortium Agreement, subject to exte… Full filing |
21.4% |
Insider purchases and sales in Q2 2025
Shares bought or sold by the company's own officers, directors and 10% owners, in the open market or privately, as they reported to the SEC on Form 4 (due within two business days of the trade). Grants, option exercises, shares withheld for tax and gifts aren't included.
None reported in Q2 2025.
Holders, Q2 2025
| Manager | Shares | Change |
|---|---|---|
| SUSQUEHANNA INTERNATIONAL GROUP, LLP 0.00% of their portfolio | 14.8k $103.7k | New |
| RENAISSANCE TECHNOLOGIES LLC 0.00% of their portfolio | 13.0k $92.9k | Added +200 |
| Connor, Clark & Lunn Investment Management Ltd. 0.00% of their portfolio | 11.3k $81.0k | Unchanged |
| UBS Group AG 0.00% of their portfolio | 6.1k $43.7k | Added +4.7k |
| MORGAN STANLEY 0.00% of their portfolio | 5.2k $36.9k | Unchanged |
| Serenus Wealth Advisors, LLC 0.05% of their portfolio | 4.6k $301.1k | Unchanged |
| SBI Securities Co., Ltd. 0.00% of their portfolio | 224 $1.6k | Reduced -38 |
| RHUMBLINE ADVISERS 0.00% of their portfolio | 22 $154 | Unchanged |
| JPMORGAN CHASE & CO 0.00% of their portfolio | 8 $56 | Reduced -62 |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. — of their portfolio | 0 $0 | Unchanged |